Researchers indicated that relapse can originate from therapy-resistant mature acute myeloid leukemia cells, and suggested differentiation therapy combined with targeted eradication of mature leukemia-derived lineages may improve disease outcome.
[Nature Communications]
6445212
BBBBBBBB
items
1
apa
0
default
asc
1
168999
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
